A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease

por Laderach, D.J., Gentilini, L.D., Giribaldi, L., Delgado, V.C., Nugnes, L., Croci, D.O., Al Nakouzi, N., Sacca, P., Casas, G., Mazza, O., Shipp, M.A., Vazquez, E., Chauchereau, A., Kutok, J.L., Rodig, S.J., Elola, M.T., Compagno, D., Rabinovich, G.A.